Join Paid Clinical Trials for the Flu (Influenza)

Paid Clinical Trials and Focus Groups


Find Paid Clinical Trials

Paid Clinical Trials - : Flu (Influenza)

Top of Directory » All Categories » by Illness » Flu (Influenza)



  • Safety and Immune Response to Adjuvanted A(H1N1)v Influenza Vaccine in HIV-1 Infected and Immunosuppressed Adult Patients

    Conditions:   HIV-1 Infection;   Cancer;   Immunosuppression
    Intervention:   Other: serologic testing
    Sponsors:   Johann Wolfgang Goethe University;   HIVCENTER
    Recruiting - verified November 2009
  • Evaluation of Influenza H1N1 Vaccine in Adults With Lymphoid Malignancies on Chemotherapy

    Conditions:   Lymphoma;   Multiple Myeloma;   Influenza A Virus, H1N1 Subtype
    Intervention:   Biological: AS03-adjuvanted H1N1 pandemic influenza vaccine
    Sponsors:   University Health Network, Toronto;   Princess Margaret Hospital, Canada
    Recruiting - verified November 2009
  • Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital

    Conditions:   Influenza A Virus, H1N1 Subtype;   Influenza B Virus;   Influenza, Human;   Influenza, Seasonal
    Intervention:   Drug: zanamivir aqueous solution
    Sponsor:   GlaxoSmithKline
    Not yet recruiting - verified November 2009
  • Safety, Efficacy and Immunogenicity Study of Fluad Versus Control Vaccines in Unprimed Healthy Children (6 to < 72 Months)

    Condition:   Influenza Disease
    Intervention:   Biological: Influenza virus vaccine: Influenza virus strains A/H1N1, A/H3N2, B
    Sponsors:   Novartis;   Novartis Vaccines
    Recruiting - verified November 2009
  • Low Doses Corticosteroids as Adjuvant Therapy for the Treatment of Severe H1N1 Flu

    Conditions:   Pneumonia, Viral;   Influenza A Virus, H1N1 Subtype
    Interventions:   Drug: hydrocortisone;   Drug: isotonic saline
    Sponsors:   University of Versailles;   Assistance Publique - Hôpitaux de Paris
    Not yet recruiting - verified November 2009
  • A Trial to Evaluate the Safety and Immunogenicity of a Trivalent Seasonal Influenza Virus-Like Particle (VLP) Vaccine (Recombinant) in Older Adults

    Condition:   Influenza
    Interventions:   Biological: Investigational Influenza VLP Vaccine 15ug/strain;   Biological: Investigational Influenza VLP Vaccine 60ug/strain;   Biological: TIV
    Sponsor:   Novavax
    Recruiting - verified November 2009
  • Immunogenicity and Safety of a Cell-derived Influenza Vaccine in Elderly

    Condition:   Influenza
    Interventions:   Biological: Influenza Vaccine;   Biological: Influenza Vaccine
    Sponsor:   Solvay Biologicals
    Not yet recruiting - verified November 2009
  • Study to Evaluate the Safety and Immunogenicity of GSK Biological Pandemic Candidate Influenza Vaccine (H1N1) in Children

    Condition:   Influenza Infection
    Interventions:   Biological: GSK pandemic vaccine GSK2340269A;   Biological: GSK pandemic vaccine GSK2340272A
    Sponsor:   GlaxoSmithKline
    Not yet recruiting - verified November 2009
  • H1N1v Vaccination of Pregnant Women: A Longitudinal Cohort Study Characterizing Influenza A H1N1v Vaccination in Pregnant Women

    Condition:   H1N1v Influenza
    Interventions:   Biological: Focetria;   Biological: Focetria;   Biological: Focetria;   Biological: Focetria
    Sponsors:   Copenhagen Studies on Asthma in Childhood;   Novartis
    Recruiting - verified November 2009
  • Characteristics and Outcomes of Intensive Care Unit Patients Admitted With Novel H1N1 Influenza or Seasonal Influenza

    Conditions:   H1N1 Influenza;   Seasonal Influenza
    Intervention:  
    Sponsor:   Virginia Commonwealth University
    Recruiting - verified November 2009
  • Panitumumab and Irinotecan for Malignant Gliomas

    Condition:   Recurrent Grade IV Malignant Glioma
    Intervention:   Drug: Panitumumab in Combination with Irinotecan
    Sponsors:   Duke University;   Amgen
    Not yet recruiting - verified November 2009
  • Safety and Immune Response of One-Dose of Candidate H1N1 Influenza Vaccine GSK2340274A in Adults

    Condition:   Influenza
    Intervention:   Biological: GSK Biologicals' investigational H1N1 Influenza Vaccine - GSK2340274A
    Sponsor:   GlaxoSmithKline
    Not yet recruiting - verified November 2009
  • Antibody Production Following H1N1 Influenza Vaccination After Stem Cell and Heart Transplantation

    Condition:   H1N1 Influenza
    Intervention:  
    Sponsor:   Hadassah Medical Organization
    Recruiting - verified November 2009
  • Trial Comparing High Versus Standard Dose Oseltamivir in Severe Influenza Infection in ICU

    Condition:   Influenza A Virus H1N1 Subtype
    Intervention:   Drug: Oseltamivir
    Sponsors:   University of Manitoba;   Hoffmann-La Roche
    Not yet recruiting - verified November 2009
  • Safety and Immunogenicity of Replication-Competent Adenovirus 4-vectored Vaccine for Avian Influenza H5N1

    Conditions:   Bird Flu;   Influenza
    Interventions:   Other: Placebo;   Biological: Ad4-H5-Vtn
    Sponsor:   PaxVax, Inc.
    Recruiting - verified November 2009
  • Vaccination Against Influenza H1N1 in Rheumatic Diseases

    Conditions:   Influenza;   Rheumatic Diseases
    Interventions:   Biological: Focetria (Monovalent MF59-Adjuvanted vaccine);   Biological: Focetria (Monovalent MF59-Adjuvanted vaccine);   Biological: Focetria (Monovalent MF59-Adjuvanted vaccine)
    Sponsor:   Tel-Aviv Sourasky Medical Center
    Not yet recruiting - verified November 2009
  • Sinovac, H1N1 Vaccine + Trivalent Inactivated Influenza Vaccine, Adults

    Condition:   Influenza
    Interventions:   Biological: H1N1 influenza A Vaccine (PANFLU.1);   Biological: Trivalent Inactivated Influenza Vaccine (ANFLU)
    Sponsor:   Sinovac Biotech Co., Ltd
    Recruiting - verified November 2009
  • Effects of Tea Catechin Consumption on the Prophylaxis of Influenza Infection

    Condition:   Influenza Infection
    Intervention:   Dietary Supplement: tea catechin extracts
    Sponsors:   University of Shizuoka;   White Cross Nursing Home
    Recruiting - verified November 2009
  • Comparison of Different Methods for Reducing Pain From Influenza Vaccine Injections

    Conditions:   Pain;   Anxiety
    Interventions:   Drug: Liposomal lidocaine;   Drug: Vapocoolant spray;   Other: Rubbing adjacent to the injection site;   Other: Distraction
    Sponsor:   The Hospital for Sick Children
    Recruiting - verified October 2009
  • Study to Evaluate Safety and Immunogenicity of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Children

    Condition:   Influenza Infection
    Interventions:   Biological: Prevenar;   Biological: GSK2340272A GSK Biologicals' investigational influenza pandemic vaccine;   Biological: InfanrixTM-IPV/Hib
    Sponsor:   GlaxoSmithKline
    Not yet recruiting - verified November 2009
  • Studies of Pandemic Influenza (H1N1) 2009 Vaccine in Bergen

    Condition:   Healthy
    Intervention:   Biological: Pandemrix
    Sponsors:   University of Bergen;   Haukeland University Hospital, N-5021 Bergen, Norway
    Recruiting - verified October 2009
  • Influenza Vaccination in Patients With Scleroderma

    Condition:   Influenza Vaccine in Scleroderma
    Intervention:   Biological: Influenza vaccine
    Sponsor:   Tel-Aviv Sourasky Medical Center
    Not yet recruiting - verified August 2009
  • The Effects of Interferon Beta Combined With Vitamin D on Relapsing Remitting Multiple Sclerosis Patients

    Condition:   Multiple Sclerosis
    Interventions:   Dietary Supplement: Vitamin D3;   Dietary Supplement: Vitamin D3
    Sponsors:   Carmel Medical Center;   Merck Serono International SA
    Not yet recruiting - verified November 2009
  • Does Seasonal Influenza Vaccination Affect the Incidence of pH1N1 Influenza?

    Condition:   Influenza
    Interventions:   Biological: Fluviral influenza vaccine, 2009-2010;   Biological: Normal saline
    Sponsors:   Mount Sinai Hospital, Canada;   GlaxoSmithKline
    Recruiting - verified November 2009
  • Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Adults With HIV

    Conditions:   HIV Infections;   H1N1 Influenza
    Interventions:   Biological: Arepanrix;   Biological: Arepanrix
    Sponsors:   University of British Columbia;   Canadian Institutes of Health Research (CIHR)
    Not yet recruiting - verified October 2009
  • Response to Influenza Virus Vaccination in Patients Immunocompromised Due to Chemotherapy

    Conditions:   Mamma Carcinoma;   Heart Failure
    Intervention:   Biological: influenza virus vaccine (influvac or vaxigrip)
    Sponsor:   St. Antonius Hospital
    Recruiting - verified October 2009
  • Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Adults Receiving Seasonal Influenza Vaccine

    Conditions:   Influenza;   H1N1 2009 Influenza
    Interventions:   Biological: Arepanrix, Vaxigrip 2009/2010;   Biological: Arepanrix, Vaxigrip 2009/2010
    Sponsors:   University of British Columbia;   Canadian Institutes of Health Research (CIHR)
    Not yet recruiting - verified October 2009
  • Rapid Evaluation of Pandemic H1N1 Influenza Vaccines in Young Children

    Condition:   H1N1/2009 Influenza
    Interventions:   Biological: Arepanrix;   Biological: Arepanrix
    Sponsors:   University of British Columbia;   Canadian Institutes of Health Research (CIHR)
    Not yet recruiting - verified October 2009
  • Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Aboriginal Children and Adults

    Condition:   H1N1/2009 Influenza
    Interventions:   Biological: Arepanrix;   Biological: Arepanrix
    Sponsors:   University of British Columbia;   Canadian Institutes of Health Research (CIHR)
    Not yet recruiting - verified October 2009
  • Oseltamivir Pharmacokinetics in Morbid Obesity

    Condition:   Morbid Obesity
    Interventions:   Other: Patients with a BMI < 30 given Oseltamivir;   Other: Patients with a BMI > 40 given Oseltamivir
    Sponsors:   IWK Health Centre;   Canadian Center for Vaccinology;   Capital District Health Authority;   Dalhousie University;   Hoffmann-La Roche
    Not yet recruiting - verified October 2009
  • Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants

    Conditions:   Haemophilus Influenzae Type B Related Disease;   Pneumonia;   Meningitis;   Cellulitis;   Osteomyelitis;   Epiglottis
    Interventions:   Biological: GSK Biologicals' Haemophilus inluenzae type b vaccine (GSK 208108);   Biological: ActHIBTM;   Biological: PentacelTM;   Biological: PediarixTM;   Biological: PrevnarTM;   Biological: RotarixTM;   Biological: EngerixTM-B;   Biological: InfanrixTM
    Sponsor:   GlaxoSmithKline
    Not yet recruiting - verified November 2009
  • Immunogenicity and Safety of Inactivated H1N1 Swine-origin Influenza Monovalent Vaccine in Immunocompromised Children and Young Adults

    Condition:   H1N1 Pandemic Flu
    Intervention:  
    Sponsor:   St. Jude Children's Research Hospital
    Recruiting - verified October 2009
  • A Double-Dose Safety Study of An Influenza Vaccine (Multimeric-001) Injected to Elderly Volunteers

    Condition:   Influenza
    Interventions:   Biological: Multimeric-001 250 mcg in PBS;   Biological: Multimeric-001 250 mcg with Adjuvant;   Biological: Placebo in PBS;   Biological: Placebo with Adjuvant;   Biological: Multimeric 500 mcg in PBS;   Biological: Multimeric-001 500 mcg with Adjuvant;   Biological: Vaxigrip
    Sponsor:   BiondVax Pharmaceuticals ltd.
    Recruiting - verified November 2009
  • Avastin/Radiation (XRT)/Temozolomide Followed by Avastin/Temozolomide/Topotecan for Glioblastoma

    Conditions:   Malignant Glioma;   Glioblastoma Multiforme;   Gliosarcoma
    Intervention:   Drug: Avastin in Combination with Radiation and Temozolomide followed by Avastin, Temozolomide, and Topotecan
    Sponsors:   Duke University;   Genentech;   GlaxoSmithKline
    Not yet recruiting - verified October 2009
  • Pivotal, Multicenter, Observer-Blind, Randomized Study of Influenza A (H1N1)2009 Monovalent Subunit Vaccine With and Without Adjuvant in Children Ages 6 to <36 Months

    Condition:   Influenza
    Intervention:   Biological: Adjuvanted and un-adjuvanted influenza vaccines
    Sponsors:   Novartis;   Novartis Vaccines
    Recruiting - verified October 2009
  • Cell Immunity Response to Vaccination Against Influenza in Patients With Rheumatoid Arthritis

    Condition:   Rheumatoid Arthritis
    Intervention:   Biological: Agrippal S1 (Influenza vaccination)
    Sponsor:   Tel-Aviv Sourasky Medical Center
    Recruiting - verified October 2009
  • Post-Authorization Safety Study of GSK Biologicals' Pandemic Influenza Vaccine (H1N1) in the United Kingdom

    Condition:   H1N1 Influenza Vaccination
    Intervention:   Other: Safety follow up
    Sponsor:   GlaxoSmithKline
    Recruiting - verified November 2009
  • Immunogenicity of Novel H1N1 Vaccination Among HIV-Infected Compared to HIV-Uninfected Persons

    Conditions:   Influenza;   H1N1;   HIV;   Vaccine;   HIV Infections
    Intervention:  
    Sponsors:   Uniformed Services University of the Health Sciences;   Infectious Disease Clinical Research Program;   National Institute of Allergy and Infectious Diseases (NIAID)
    Not yet recruiting - verified October 2009
  • Characterization of the Innate Immune Response in Healthy NIH Employees at Baseline and After Immunization With the H1N1 Vaccine

    Condition:   Healthy Volunteers
    Intervention:  
    Sponsors:   Center for Human Immunology (CHI);   Center for Human Immunology
    Recruiting - verified September 2009
  • The Use of Certolizumab Pegol in Adult Subjects With Rheumatoid Arthritis to Assess the Antibody Response When Receiving Influenza Virus and Pneumococcal Vaccines

    Condition:   Rheumatoid Arthritis
    Interventions:   Biological: Placebo;   Biological: Certolizumab pegol
    Sponsor:   UCB, Inc.
    Recruiting - verified November 2009
  • Safety of and Immune Response to an H1N1 Influenza Virus Vaccine in HIV Infected Children and Youth

    Conditions:   HIV Infections;   H1N1 Influenza Virus
    Intervention:   Biological: Influenza A (H1N1) 2009 monovalent vaccine
    Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
    Not yet recruiting - verified October 2009
  • H1N1 Vaccine at Two Dose Levels in HIV Positive Adults

    Condition:   Influenza
    Intervention:   Biological: Inactivated Influenza H1N1 vaccine
    Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
    Recruiting - verified October 2009
  • Novartis H1N1 Vaccine in Pregnant Women

    Condition:   Influenza
    Intervention:   Biological: Inactivated H1N1 Vaccine
    Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
    Recruiting - verified November 2009
  • Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women

    Conditions:   HIV Infections;   H1N1 Influenza Virus
    Intervention:   Biological: Influenza A (H1N1) monovalent vaccine
    Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
    Recruiting - verified October 2009
  • Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline Biologicals' Influenza Vaccine in Elderly People

    Condition:   Influenza Infection
    Interventions:   Biological: FluarixTM;   Biological: GSK investigational vaccine 2186877A
    Sponsor:   GlaxoSmithKline
    Recruiting - verified November 2009
  • A Pilot Study for Collection of Anti-Influenza A H1N1 (Swine Flu) Hyper-Immune Plasma

    Conditions:   H1N1 Influenza;   Swine Flu
    Intervention:  
    Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
    Recruiting - verified August 2009
  • Immunogenicity and Safety Study of a GlaxoSmithKline Biologicals' Candidate Influenza Vaccine in Healthy Children

    Condition:   Influenza
    Interventions:   Biological: Influenza vaccine GSK2321138A;   Biological: Fluarix™
    Sponsor:   GlaxoSmithKline
    Recruiting - verified October 2009
  • Safety and Immunogenicity of H1N1 Vaccines in Adults Aged 18 Years and Older

    Condition:   Influenza Infection
    Interventions:   Biological: GSK2340273A;   Biological: Saline placebo;   Biological: GSK2340274A
    Sponsor:   GlaxoSmithKline
    Recruiting - verified November 2009
  • Swine Flu (Novel Influenza A H1N1) Vaccine Study

    Condition:   Influenza
    Interventions:   Biological: Baxter Novel Influenza A H1N1 Whole Virus Vaccine;   Biological: GlaxoSmithKline Novel Influenza A H1N1 Split Virion Vaccine
    Sponsor:   University of Oxford
    Recruiting - verified October 2009
  • A Clinical Trial Comparing Oseltamivir With Placebo And Zanamivir With Control As First Line Treatment For Human Swine Influenza Infection

    Conditions:   Upper Respiratory Tract Infection;   Influenza
    Interventions:   Drug: Oseltamivir;   Drug: Zanamivir;   Drug: Placebo of Oseltamivir
    Sponsors:   Chinese University of Hong Kong;   Hospital Authority, Hong Kong;   Food and Health Bureau, Hong Kong
    Recruiting - verified November 2009
    • Menu
    Find Paid Clinical Trials